Skip to content

BioZorb F0405Recalls & reported problems

Hologic, Inc. · BioZorb Marker · Class 2 · Implant

All models of BioZorb (9)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

2 open recalls name this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
2

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 15420045514065), received between Aug 27, 2024 and Aug 27, 2024 — classified as 1 injury.

2 FDA recall records name this device's identifier, 2 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 1 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Recalls naming this device

  1. Oct 10, 2024Open, Classified

    Firm received reports of adverse events/complications that include serious injuries, such as pain, infection, rash, device migration, device erosion, seroma, and discomfort.

    Z-0328-2025 · Root cause: Device Design · Recall details · FDA record ↗

  2. Mar 13, 2024Open, Classified

    Safety Information: Complaints describe complications/adverse events that include pain, infection, rash, device migration, device erosion, seroma, discomfort, or other complications from feeling the device in the breast, and the need for additional medical treatment to remove the device

    Z-1733-2024 · Root cause: Unknown/Undetermined by firm · Recall details · FDA record ↗

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Breast Discomfort/Pain1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 27, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT A 69 YEARS OLD FEMALE PATIENT RECEIVED A BIOZORB IMPLANT IN (B)(6) 2022 AND REMOVED ON (B)(6) 2024 ON HER RIGHT BREAST. PATIENT COMPLAINED OF PAIN AT THE SITE OF IMPLANTATION, THE MARKER WAS REMOVED AND THE SURGEON REPORTED FOUND THE MARKER IN PIECES. PATIENT REPORTED THAT PRIOR TO REMOVAL OF DEVICE THERE WAS A PERSISTENCE OF LUMP, PINCHING AND SHARP PAINS, TENDER TO TOUCH, FELT THAT SHIFTED AND HAD CHANGED SHAPE. IT WAS REPORTED THAT THE STRUCTURE HAD COLLAPSED AND LAYING FLAT COMPRESSED AND SIDEWAYS, REMOVAL REQUIRED EXTENSIVE EXPLORATION OF THE CAVITY. AN IMAGE OF THE DEVICE EXPLANTED WAS PROVIDED IN WHICH SEVERAL PIECES WERE OBSERVED. NO OTHER INFORMATION AVAILABLE.

    Patient problems: Breast Discomfort/Pain

    MAUDE report 20077999 ↗

Other MARKER, RADIOGRAPHIC, IMPLANTABLE devices

All MARKER, RADIOGRAPHIC, IMPLANTABLE devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page